Healthcare groups urge FDA to act on compounding regulations after GLP-1 medicine shortages https://www.byteseu.com/855631/ ##WomensHealth #diabetes #EDUCATION #Food #GLP1 #Health #Healthcare #Medicine #Obesity #semaglutide #WeightLoss
Healthcare groups urge FDA to act on compounding regulations after GLP-1 medicine shortages https://www.byteseu.com/855631/ ##WomensHealth #diabetes #EDUCATION #Food #GLP1 #Health #Healthcare #Medicine #Obesity #semaglutide #WeightLoss
https://www.europesays.com/1935241/ Healthcare groups urge FDA to act on compounding regulations after GLP-1 medicine shortages #america #diabetes #education #Entertainment #Food #GLP1 #health #healthcare #medicine #obesity #Semaglutide #sports #UnitedStates #UnitedStatesOfAmerica #US #USA #WeightLoss #Women'sHealth
Eye doctors at the University of Utah Health and elsewhere published the research, which describes several cases of vision complications possibly tied to these obesity and diabetes drugs. The medications were linked to three different eye conditions, all of which can lead to blindness. But as the doctors caution, the cases alone do not prove that GLP-1 drugs can cause these issues, and more research is needed to understand exactly what’s going on. #health #GLP1 https://gizmodo.com/eye-doctors-are-finding-new-links-between-ozempic-and-vision-problems-2000563080
Republicans want you fat, uneducated, starving, and homeless. Call your Republican Senators and Representatives.
GOP sharply divided over coverage of popular weight-loss drugs
https://www.alternet.org/ozempic-gop-semafor/
Sorry, #dulaglutide med #trulicity; the more general description of these drugs is #glp1 receptor agonists.
Apparently various professional orgs have been kinda all over the map on whether or not to hold such meds pre-op, but now they are coalescing -- still without formal evidence-based guidance, mind you -- around 24-hour liquid diet in preoperative phase, especially for higher doses of the meds for patients on weekly regimens.
“And I think a 39% risk reduction is one of the most impactful risk reductions we've ever really seen” #WeGovy #semaglutide #ozempic #glp1 #cancer #HealthCare https://www.npr.org/sections/shots-health-news/2024/08/11/nx-s1-5003714/ozempic-wegovy-glp-1-obesity-cancer-prevention
For diabetes patients, GLP-1 drugs linked to lower cancer risks compared to insulin, Ars Technica reports:
https://arstechnica.com/science/2024/07/new-weight-loss-and-diabetes-drugs-linked-to-lower-risk-of-10-cancers/
Calling this trial "positive" simply doesn't do it justice.
This is an outrageously positive trial.
I've long been a proponent of #GLP1 as first line for DM. I'd say the same should probably be true for anyone with obesity and an obesity related condition (HTN/DM/HFpEF). I'm even more excited for the more potent agents to be trialed. Primary care is slowly going to evolve into a #GLP1 prescribing.
https://www.nejm.org/doi/full/10.1056/NEJMoa2306963?query=featured_home
@leo didn't you say that your daughter told you that you were not to start taking any #GLP1 class drugs because she didn't like that you would have to KEEP taking them for life? You and she may be interested to read this new Wired article. https://www.wired.com/story/ozempic-wegovy-quitting-weight-loss/?bxid=5ee10a3585e9ed3cd5e7047b&cndid=15731479&esrc=AUTO_PRINT&mbid=mbid%3DCRMWIR012019%0A%0A&source=Email_0_EDT_WIR_NEWSLETTER_0_DAILY_ZZ&utm_brand=wired&utm_campaign=aud-dev&utm_content=WIR_Daily_070723&utm_mailing=WIR_Daily_070723&utm_medium=socialshare&utm_source=adreanalangston&utm_term=P4
But what's lost in the pushback is that the treatment of individuals who presently have obesity must be considered separately from questions about prevention and obesity’s environmental causes.
And right now, the best treatments we have are #bariatricsurgery and #GLP1-based obesity medications such as #ozempic. Even for adolescents.
I wrote how I came around to this view, and why it's less radical than it sounds at a glance
@SubstackInc https://juliabelluz.substack.com/p/what-to-do-about-children-with-obesity